Physician

Samuel Alan Amen, M.D.

According to 2025 Medicare claims, Samuel Amen, M.D. (NPI: 1831300995) practices addiction medicine in the North Port-Bradenton-Sarasota, FL market, with the plurality of this provider's patient population coming from Sarasota, FL. This provider's primary affiliated billing organization is ANESTHESIA AND PAIN PHYSICIANS OF FLORIDA, PA (NPI: 1982815080; TIN: 43-1962888) and primary practice location at 34205-8641. Amen is affiliated with the Subsero Healthcare, LLC d/b/a MAX Healthcare #1 (ACO ID: D0172), participating under the REACH model.

Amen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 453 traditional Medicare patients, billed 1,162 HCPCS/CPT codes, and received $98,145 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 11,556 prescription claims across 1,927 beneficiaries totaling $713,866 in drug costs, led by Belbuca (Buprenorphine Hcl). 2016 DME data shows 17 claims. Open Payments data shows 8 records totaling $187. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $5,194 and ending at $98,145. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $59,093 and ending at $713,866. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	67	94	$5,194
2016	413	1,710	$73,521
2017	242	2,784	$168,691
2018	736	6,694	$337,970
2019	709	4,600	$254,465
2020	148	264	$19,701
2021	91	173	$16,397
2022	140	302	$27,459
2023	278	794	$69,697
2024	453	1,162	$98,145

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	164	500	$59,093
2016	434	4,116	$402,326
2017	504	4,302	$397,541
2018	898	6,734	$681,447
2019	893	5,262	$535,310
2020	530	4,152	$322,319
2021	484	4,900	$434,292
2022	679	5,128	$442,822
2023	1,103	6,331	$498,453
2024	1,927	11,556	$713,866

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	17	$352
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	438	893	$93
80307	Testing for presence of drug, by chemistry analyzers	166	234	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Belbuca	Buprenorphine Hcl	383	10,729	$300,011
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	1,966	53,206	$69,377
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1,847	48,956	$40,305
Buprenorphine	Buprenorphine	192	5,314	$36,126
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	220	6,193	$28,449

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$187	Collegium Pharmaceutical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Samuel Alan Amen, M.D.?

Tedicare shows public-source Medicare data for Samuel Alan Amen, M.D. (NPI 1831300995), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Samuel Alan Amen, M.D. have ACO affiliation data?

Samuel Alan Amen, M.D. is shown with ACO affiliation data for Subsero Healthcare, LLC d/b/a MAX Healthcare #1 (REACH, ACO ID D0172).

What billing organization is linked to Samuel Alan Amen, M.D.?

Samuel Alan Amen, M.D. is linked to ANESTHESIA AND PAIN PHYSICIANS OF FLORIDA, PA (billing NPI 1982815080) in the available physician profile data.

Does Samuel Alan Amen, M.D. have Open Payments data?

Samuel Alan Amen, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.